Capital Biosciences is a Biospecimen CRO based out of Washington DC, dedicated to providing high-quality clinically annotated biospecimens to researchers around the world. CBI offers access to geographically diverse patients population, consistent and uniform collection protocols across all sites, full chain of custody approach for specimen collection, data reporting, flexible study design and ability to accommodate custom protocols. We have highly experienced PIs & dedicated hospital staff, well established and robust quality control system, consistent and thorough sites monitoring, as well as full access to patients medical records including treatment and outcome.